Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia

Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia

Abstract Despite the considerable progress in understanding the molecular bases of acute myeloid leukemia (AML), new tools to link disease biology to the unpredictable patient clinical course are still needed. Herein, high-throughput metabolomics, combined with the other “-omics” disciplines, holds...

Full description

Bibliographic Details
Main Authors: Matteo G. Carrabba, Laurette Tavel, Giacomo Oliveira, Alessandra Forcina, Giacomo Quilici, Francesca Nardelli, Cristina Tresoldi, Alessandro Ambrosi, Fabio Ciceri, Massimo Bernardi, Luca Vago, Giovanna Musco
Format: Article
Language:English
Published: BMC 2016-10-01
Series:Journal of Hematology & Oncology
Subjects:
Acute myeloid leukemia
Metabolomics
Patient-derived xenografts
Nuclear magnetic resonance
Online Access:http://link.springer.com/article/10.1186/s13045-016-0346-2

Internet

http://link.springer.com/article/10.1186/s13045-016-0346-2

Similar Items